跳至主要内容
临床试验/ACTRN12612001226897
ACTRN12612001226897已完成4 期

Fenofibrate in the Management of Abdominal Aortic Aneurysms

James Cook University0 个研究点目标入组 42 人开始时间: 2012年11月20日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • Ability to provide written informed consent
  • Diagnosis of an asymptomatic abdominal aortic aneurysm which is infrarenal in location and is equal to or greater than 50mm in diameter
  • Planned elective open repair of infrarenal abdominal aortic aneurysm
  • High likelihood of medication compliance

排除标准

  • Current use of any fenofibrate or related fibrates
  • contra-indication to fenofibrate including; liver impairment demonstrated by abnormal liver function tests (greater than or equal to 1.5 times normal upper limit); renal impairment (serum creatinine greater than or equal to 150 micromole); symptomatic gallbladder disease; previous reaction to any lipid modifying medication.
  • Previous aortic surgery
  • A Mycotic abdominal aortic aneurysm
  • A requirement for emergency or urgent open abdominal aortic aneurysm repair
  • Current enrolment in any other drug trial

研究者

相似试验